5G9.SI - Tritech Group Limited

SES - SES Delayed Price. Currency in SGD
0.0000 (0.00%)
At close: 5:04PM SGT
Stock chart is not supported by your current browser
Previous Close0.0240
Bid0.0240 x 0
Ask0.0250 x 0
Day's Range0.0240 - 0.0250
52 Week Range0.0130 - 0.0760
Avg. Volume12,278,367
Market Cap23M
Beta (5Y Monthly)0.32
PE Ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2012-08-02
1y Target EstN/A
  • Moody's

    CentralSquare Technologies, LLC -- Moody's announces completion of a periodic review of ratings of CentralSquare Technologies, LLC

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of CentralSquare Technologies, LLC and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.

  • Moody's

    CentralSquare Technologies, LLC -- Moody's downgrades CentralSquare's CFR to Caa1; outlook is negative

    Moody's Investors Service ("Moody's") downgraded CentralSquare Technologies, LLC's ("CentralSquare", formerly known as SuperMoose Borrower, LLC) Corporate Family Rating ("CFR") to Caa1 from B3, and Probability of Default rating ("PDR") to Caa1-PD from B3-PD. Moody's also downgraded the ratings on the company's first lien credit facilities to B3 from B2, as well as the ratings on CentralSquare's second lien term loan to Caa3 from Caa2. The rating downgrades are driven by CentralSquare's weaker than expected operating performance since the company was formed in September 2018, diminished liquidity, and Moody's expectations of softer than expected operating results and cash flows over the next 12 to 18 months.